CD4 and neoplasm: In a mouse model of epithelial ovarian cancer (EOC) in vitro transfection of CD4+ T cells with miRNA 29a-3p and miR-21-5p mimics, complexed with the commercially available X-tremeGENE siRNA transfection reagent, followed by adoptive transfer into tumor-burdened mice, tumor growth was attenuated [237].